Description
The Department of Veterans Affairs intends to solicit and negotiate with Boston Scientific for TheraSphere Y-90 Doses, a therapeutic agent used to treat unresectable primary Hepatocellular Carcinoma. The Government believes that only one business can satisfy the agency requirements. Other interested parties may identify their interest and capability to respond to this requirement by the specified deadline. The scope of work includes the supply of TheraSphere Y-90 Doses. Key aspects of the job include:
* Treating unresectable primary Hepatocellular Carcinoma
* Using microscopic glass spheres attached to a radioactive isotope (Y-90)
* Injecting the spheres into the patient, where they become trapped in the liver to treat liver cancer
* Supplying TheraSphere Y-90 Doses to the Department of Veterans Affairs